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“Renaturable” leucine transfer ribonucleic acid 
from baker’s yeast was found by Lindahl et al. [l] to 
be able to exist in a relatively stable denatured con- 
figuration which has only low amino acid acceptor 
activity. Incubation at 60’ for 5 min, followed by 
slow cooling in the presence of magnesium ion, was 
found to disrupt the incorrect cornformation and 
allow renaturation to -the native, biologically active 
structure. Although the physiological significance of 
the reversible denaturation process, if any, is not 
known, it is of interest to try to determine if there is 
a unique feature of the primary or secondary struc- 
ture that would account for the stability of the second, 
inactive conformation. The “renaturable leucine 
tRNA (tRNAy)** was purified in our laboratory 
by sucessive chromatography on benzoylated DEAE 
cellulose and Sephadex G-100 columns [2]. We deter- 
mined the nucleotide sequence of this tRNA [3] by 
Holley’s method [4]. In this paper, we would like to 
report our results and compare them with those 
recently reported by Kowalski et al. [S] . 
Purified tRNALeU was digested with pancreatic 
ribonuclease [2] .“The identity of the products from 
this digestion are shown in table 1. Sequence analyses 
* Part III in a series, “Studies on yeast leucine transfer ribo- 
nucleic acid”; part II, ref. [6]. 
** Abbre iations used are tRNA, transfer ibonucleic acid; 
tRNAEeu “renaturable” leucine tRNA; standard abbre- 
viatior?s ark used for the four major nucleosides; AcC, 
N4-acetylcytidine; diHU, 5,64hydrouridme, SmC, 
Smethylcytidine; T, ribothymidine; 2mG, N*-methyl- 
guanosine; 2’0mG, 2’4methylguanosine; dimG, 
N*-dimethylguanosine; lmG, N’-methylguanosine; 
RNase, ribonuclease. 
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on these fragments were described in [2] . The nucleo- 
tides, including those of minor bases, were identified 
by their spectra at neutral, acidic and basic pH. 
The tRNA was also digested with T, ribonuclease 
[6] . To determine their nucleotide sequences, the 
purified T, fragments were further digested with pan- 
creatic RNase, alkaline phosphatase, snake venom 
phosphodiesterase, or polynucleotide phosphorylase 
(singly or in combinations), and the products were 
isolated by paper or column chromatography and 
identified by their spectra. Details of this procedure 
were given in [6] . The identity of the T, RNase 
digestion products are shown in table 2. 
Large oligonucleotides were obtained from partial 
digestion of tRNALeU . with T, RNase. After the first 
digestion, described in fig. 1, fragments 1 (from the 
5’-end to the dihydrouridine loop) and 2 (the re- 
mainder of the molecule) were obtained. Fragment 2 
was further digested as described in fig. 1 to obtain 
the three oligonucleotides shown. This result indicates 
that in this tRNA the diHU loop is more susceptible 
to T, RNase attack than is the anticodon loop. This 
resistance of the anticodon stem and loop to T, Rnase 
digestion was also evident from the “complete” diges- 
tion of this tRNA with T, RNase. As shown in table 
2 the longest fragment was a product of incomplete 
action of the T, RNase and was found to contain the 
entire anticodon stem and loop. Since there are un- 
substituted guanosines in this region which should be 
susceptible to T, RNase, it would seem that this 
region has a very compact tertiary structure in the 
“denatured” configuration that the tRNA was in at 
the time of digestion. 
From the results of the complete pancreatic RNase 
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Table 1 
products formed by complete degradation of tRNAp with 
pancreatic ribonuclease 
COH 
8-9 Cp + 7-8 Up 
AcCp + SmCp + J, p + diHUp 
dimGpCp 
~GPUP 
GpSmCp 
APUP 
APGP 
2’-OmGpGpdiHUp 
GPAPQ P 
APGPCP 
APAPCP 
Gp2mGpCp 
GPAPAPUP 
ApAplmGpCp 
GPAPGPCP 
APGPGPCP 
PGPGP’JP 
APAPGPGPGP 
APAPGPAPHP 
APAPGPAPGPTP 
-~- 
digestion, the complete T, and partial T, RNase 
digestions, the primary nucleotide sequence of 
tRNAp was derived and arranged in the cloverleaf 
secondary structure shown in fig. 2. The only 
ambiguity in this sequence is the order of two T, 
oligonucleotides UUG and UUUG. The order shown 
was derived from two considerations: (i) All known 
tRNA’s have a uridine at position 8, and (ii) this 
sequence allows maximum base pairing in the amino- 
acid-acceptor stem. 
Table 2 
products formed by complete degradation of tRNAp with 
Tt ribonuclease 
-- -__ 
2mGp UPUPUPGP 
~GP UPAPAPGP 
~APGP SmCpApApGp 
CPA~‘WP CPAPAPCPCPAPCPCGH 
UPUPGP diHUpCpdiHUpApApGp 
PGP APAPUPCPWPUPUPAPGP 
Cp2’-OmGpGp CpdimGpCpCpUpGpAp$pUpSmCpApAp- 
APUPGP 1mGpCpCpCpApGpCpUpApUpCpGp 
TPJ, PCPCP 
This tRNA is 85 nucleotides in length and has 
SmC-A-A as the anticodon. The anticodon stem of 
this tRNA contains only four base pairs while all other 
tRNA’s with established structure have five in the 
same region. This leaves nine unpaired bases in the 
anticodon loop, as opposed to the usual seven. As in 
the case of E. coli tRNALeU and yeast tRNAAF, 
N’ -methylguanosine is adjacent to the 3’ side of the 
anticodon of this tRNA. 
Kowalski et al. recently reported the nucleotide 
sequence of the “denaturable” leucine tRNA [5] . 
This sequence, shown in fig. 3, was determined using 
Leu 
Nucleotide Sequence of Yeost tRNA a 
2m AC z?Orn diti doH dpl Fun Im sm 
pGGUUGUUUGGCCGAGCGGlC~~GGCGCCUGAPUCAAGCCCAGGUAUCGUAAGAUGCAAGAGT~CGAAUCUCUUAGCAACCACCAon 
Lorge Oligonucledide Frogments 
2,“! AC 
PGGUUGUUUGGC~AG C%CUGA’t’U%&CCAGGUAUCG AAUCUCUUAGCAACCACCOH 
I 3 5 
UAAGAUG%AAGAGTYCG 
4 
2’0m dH dlH 
Ci;GirCliAAGccd;imcCUGA~U5~AA’~CCCAGG~UC~AAGAU~~AAGAGTVCOAAUCUCUUAGCAACCACCo~ 
2 
Fig. 1. Nucleotide sequences of oligonucleotides obtained from partial degradation of tRNALeU with Tr RNase. Approximately 
1000 absorbance units* of the purified tRNA was incubated with 15,000 units of Tr RNaseaat 0” for 20 min. Chromatography of 
the products on a DEAE cellulose in the presence of 7 M urea gave fragments 1 and 2. Further digestion of fragment 2 (300 
absorbance units with 100,000 units of Tr RNase at 0” for 10 min and separation of the products on a DEAE cellulose column at 
55” in the presence of 7 M urea gave fragments 3,4 and 5. 
* One absorbance unit is defmed as that amount of material per ml of solution which produces an absorbance of 1 in a 1 cm light 
path at 260 mn. 
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f? 
C AC 
PO-C 
bG 
G 
CGAGk~~ 
eH"CeAA GGEG 
,CAAGAGT 
FUAG 
C-GU'I A 
C-G *U’ * 
;I$ CG” 
$ t.. 
u I--G 
smC A A 
Fig. 2. Nucleotide sequence of “renaturable” leucine tRNA 
from baker’s yeast. 
the Sanger method [7] of 32P labeling and two-dimen- 
sional electrophoresis. Assuming that the two sequen- 
ces are of the same tRNA, this is the first time the 
nucleotide sequence of a tRNA has been simultaneous- 
ly and independently determined by both the Holley 
and Sanger methods. Although the sequences are not 
identical, it can be seen that there is good agreement 
between the results obtained by the two methods. 
While conclusive identification of the minor bases was 
not made in the Kowalski sequence, their tentative 
identification [5] agrees with the minor bases which 
we found [2,3]. 
It can be seen by comparison of the two sequences 
that there are three points of disagreement: (i) Our 
sequence has diHU-C-diHU in the dihydrouridine loop, 
while theirs has diHU-diHU-C. (ii) Our sequence has 
a SmC-A-A anticodon, and theirs has an unsub- 
stituted C-A-A anticodon. (iii) We found a cytidine 
at position 40, while they found a pseudouridine at 
this position. 
We have found that the difference in the nucleotide 
at position 40 did not result from differences in sen- 
sitivity of detection and identification in the two 
methods used. In a subsequent purification of 
“renaturable” leucine tRNA (unpublished results), we 
obtained a “renaturable” leucine tRNA that was the 
major leucine-accepting peak but which had a much 
different mobility on the BD-cellulose column under 
the same conditions used in isolation of tRNAF. 
Preliminary studies of the T, RNase digestion products 
AAGGCE 
Wt;GAGT* c 
c-G:‘?~A 
C-G “IJ’ * 
;I; CG” 
A-Y_ 
u c 
u l CA*O 
Fig. 3. Nucleotide sequence determined by Kowalski et al., for 
“denaturable” leucine tRNA from baker’s yeast (from [S] ). 
of this second “renaturable” leucine tRNA indicated 
that it has nearly the same base composition as the 
first, including the anticodon SmC-A-A. We found, 
however, that this tRNA contains a pentanucleotide 
which corresponds to our C-C-C-A-G sequence, 
but which contains C,A-G, and J/. It would, therefore, 
seem that it has a pseudouridine instead of a cytidine 
at position 40. This observation suggests that there 
are two types of “renaturable” leucine tRNA in yeast 
with respect to the nucleotide at position 40 (design- 
ated as 40C tRNAL”U and 40$~ tRNALeU respectively). 
The relationship between these two types of leucine 
tRNA is not known. It would seem logical to suggest 
that 40C tRNAbu is a precursor to 4OJ/ tRNALeU , 
with the C being converted into a $. It is, however, 
generally believed that J, is derived from U, not C 
[8- 1 l] , leading to the possibility that 40C tRNALeU 
is a mutant form of 4OJ/ tRNALeU. The J/ + C sub- 
stitution at position 40 reduces the number of base 
pairs from five to four in the anticodon stem. As found 
in the mutant species of E. coli suppressor tryptophane 
tRNA [ 121, the loss of a base pair in the double helical 
region probably converts the tRNA into a less stable 
structure. However, since the leucine tRNA reported 
by Kowalski is also “renaturable” and has five base 
pairs in the anticodon stem, it is uncertain whether or 
not the presence of only four base pairs in the anti- 
codon stem of our “renaturable” leucine tRNA is 
responsible for the stability of its denatured form. 
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